Saturday, October 3, 2026

USD/EUR Is 2% Down In The Last 21 Sessions

ViaNews Editorial Team

December 1, 2023

USD/EUR Is 2% Down In The Last 21 Sessions

(VIANEWS) - USD/EUR (USDEUR) has been up by 2.94% for the last 21 sessions. At 05:07 EST on Friday, 1 December, USD/EUR (USDEUR) is $0.92.

USD/EUR's yearly highs and lows, it's 3.36% up from its 52-week low and 4.679% down from its 52-week high.

Volatility

USD/EUR's last week, last month's, and last quarter's current intraday variation average was a negative 0.15%, a negative 0.18%, and a positive 0.31%, respectively.

USD/EUR's highest amplitude of average volatility was 0.30% (last week), 0.36% (last month), and 0.31% (last quarter), respectively.

News about

  • Eur/usd slipping back as the 1.1000 handle begins to look more like a ceiling that a goal. According to FXStreet on Wednesday, 29 November, "The Euro has climbed over 5% against the US Dollar since October's swing low into 1.0450, and the EUR/USD is holding in the green for the year, but 2023's mid-year peak at 1.1275 is weighing on the long-term trend as the pair gets weighed down near 1.1000 with technical indicators leaning into overbought territory.", "With the 50-day SMA still drifting on the low side of the 200-day SMA, a bullish crossover of the two moving averages will go a long way towards providing technical support for a sustained move higher, though the EUR/USD may need to fall back into the 1.0850 region to kick that off."
  • Eur/usd remains capped under the 1.1000 mark, eurozone hicp, US PCE eyed. According to FXStreet on Thursday, 30 November, "The EUR/USD pair struggles to gain ground above 1.1000 during the early Asian trading hours on Thursday. "
  • Eur/usd maintains its position above 1.1000 ahead of Spain, Germany CPI data. According to FXStreet on Wednesday, 29 November, "The EUR/USD pair is benefiting from the softer US Dollar (USD), which is influenced by a less hawkish stance from the US Federal Reserve (Fed)."
  • Eur/usd forex signal: head and shoulders pattern forms - 29 November 2023. According to DailyForex on Wednesday, 29 November, "The EUR/USD pair has been in a strong uptrend after bottoming at 1.0450 in Octover. ", "Forex Brokers We Recommend in Your Region See full brokers list 1 Read full review Get Started BrokerGeoLists.push({type:'ReviewsNonPartner',id:'horizontal-top-5',size:5,fullReviewText:`Read full review`,getStartedText:`Get Started`,readReviewText:`Review`});Bearish viewSell the EUR/USD pair and set a take-profit at 1.0900."
  • According to FXStreet on Thursday, 30 November, "This means that the broad EUR/USD trend will largely define that of GBP/USD - unless we get some enormous independent move in Sterling. ", "That probably means GBP/USD trading in the 1.20-1.25 range for the next three to six months (with perhaps some downside risks), before better Eurozone growth in the second half of 2024 and lower US rates allow EUR/USD and GBP/USD to make their moves higher."

More news about USD/EUR (USDEUR).

ViaNews Editorial Team

Via News Editorial Team delivers comprehensive financial news coverage and market analysis from journalists around the world. Our team specializes in data journalism and in-depth reporting on stock markets, business developments, and economic trends.

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
Pharma Pipeline Catalysts and M&A Heat Up as AI-Designed Drugs Enter the Clinic
Late-September 2026 brought a dense run of clinical readouts: Novo Nordisk's CagriSema data at EASD, Lilly's ADtouch results for EBGLYSS, and Merck's tulisokibart Phase 2b result. Lilly's $2.9B Merida Biosciences acquisition and the 2026-11-14 FDA PDUFA date for ivonescimab sit alongside these as the main deal and regulatory events. AI-designed drugs such as rentosertib, and speculative AI-linked trial ventures such as QAIAx, are moving from hype toward clinical validation. Broader AI-sector regulatory and legal friction (Tesla Cybercab probe, xAI Minnesota ruling, OpenAI lawsuits) shows rising scrutiny that could spill into AI-driven healthcare.
Our read on the data ›
Signals we're tracking
Satellite-Terrestrial Network Integration Acceleration
Increased investment and launches in hybrid satellite-cellular networks across telecom industry; competitive responses from other carriers; regulatory activity around satellite spectrum; expansion of emergency/rural connectivity use cases
Patterns we're watching ›
Where sources disagree
Apple Inc.
The observation date (2025-12-27) precedes Q1 2026, making it logically impossible to have actual Q1 2026 cash data at that point. Q1 2026 would not end until March 31, 2026. Additionally, the magnitude of the difference ($45.3B vs $132.42) is implausibly large even as a normal quarterly change for Apple. While different fiscal periods can show different values, the timing relationship here suggests a data integrity issue rather than legitimate period-over-period variation.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,985
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,985 facts checked against source5,329 source documents archived
Query this data → isubstrate.com